- Afferent raises $55m from IPO-focused investors
- Australian cash for new drugs comes with strings
- What else will 2Q 2015 bring?
- FDA panel backs Breo adult asthma use; rejects adolescents
- PROFILE: Antisense pioneer Stanley Crooke on injustice, the American dream, and letting go
- Profile: GSK's Arturo Gonzalez on ethics, corruption and window cleaning